Skip to content

A research on the risk factors of prognosis of living kidney donors and recipients

Analysis of the risk factors of prognosis of living kidney donors and recipients: an intermediate stage's follow-up

Status
Active, not recruiting
Phases
Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OCH-09000445
Enrollment
Unknown
Registered
2009-06-25
Start date
2005-10-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

living kidney transpplantation

Interventions

observation group:200 living renal donors and recipients

Sponsors

Sun Yat-Sen University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: In addition to the conformity of donor-recipient relationships to legislations, the following four basic evaluations should be included: 1. Risk is low for the donor. 2. The donor is completely informed. 3. The donor is voluntary without indications or coercion. 4. High likelihood for the recipient to have a good prognosis. The donor and recipient were linear blood relatives, adjacent consanguinities within three generations, couples or relatives formed by financial support. Before operation, all the relationships should be accredited by law and approved by the ethic committee of the hospital. Inclusion criteria of physiological examination: 1. The blood types were conformed to the blood transfusion principle; 2. The subjects were adults with independent behavioral ability, that is, those aged above 18, without psychiatric disorders; 3. Self-reported healthy individuals without past history of severe cardiovascular diseases, renal diseases, infectious diseases and diabetes mellitus, as well as malignant tumors.

Exclusion criteria

Exclusion criteria: Exclusion criteria of physiological examinations: 1. The fasting blood glucose or glucose tolerance was impaired; 2. Those with systolic blood pressure more than 140 mmHg or diastolic blood pressure more than 90 mmHg in consecutive three days measured twice at different hour every day, and the blood pressure could not be controlled below 140 mmHg/90 mmHg with single antihypertensive agent; 3. Those found to have malignant tumors or undetermined occupied lesions; 4. Those identified to be the carriers of HBV, or infected with HBV, HCV, syphilis, and HIV; 5. Those with abnormal renal functions, presented as elevated creatinine and urea nitrogen, more than 150 mg of the 24 h urine protein quantification, GFR< 70ml/min detected by nuclide, persistent microscopic blood urine with malformed RBC more than 10000 / ml in three urinary RBC phase tests; 6. Those with diseases of cardiovascular or hematological systems that might influence the operation; 7. Those with bilateral urinary calculi or unilateral calculi that significantly impaired ipsilateral renal function; 8. Those with positive lymphocytotoxic test.

Design outcomes

Primary

MeasureTime frame
quantitation of decoy cell under light microscope, amplification of PCR (BK virus);BMI,BP,urine protein,microscopic blood urine;biopsy of renal graft;serum creatinine;cystatinc;SF-36 health survey scale;

Countries

China

Contacts

Public ContactLizhong Chen
clz@medmail.com.cn+86 13902303569

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026